|
FANCONI ANEMIA, COMPLEMENTATION GROUP O
|
|
0.700 |
CausalMutation
|
CLINVAR |
Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing.
|
26681312 |
2016 |
|
Neoplastic Syndromes, Hereditary
|
|
0.700 |
CausalMutation
|
CLINVAR |
Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing.
|
26681312 |
2016 |
|
FANCONI ANEMIA, COMPLEMENTATION GROUP O
|
|
0.700 |
CausalMutation
|
CLINVAR |
Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population.
|
26261251 |
2015 |
|
FANCONI ANEMIA, COMPLEMENTATION GROUP O
|
|
0.700 |
CausalMutation
|
CLINVAR |
Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer.
|
25452441 |
2015 |
|
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3
|
|
0.700 |
CausalMutation
|
CLINVAR |
Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population.
|
26261251 |
2015 |
|
FANCONI ANEMIA, COMPLEMENTATION GROUP O
|
|
0.700 |
CausalMutation
|
CLINVAR |
Deleterious RAD51C germline mutations rarely predispose to breast and ovarian cancer in Pakistan.
|
24800917 |
2014 |
|
Neoplastic Syndromes, Hereditary
|
|
0.700 |
CausalMutation
|
CLINVAR |
Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes.
|
24549055 |
2014 |
|
Neoplastic Syndromes, Hereditary
|
|
0.700 |
CausalMutation
|
CLINVAR |
RAD51C--a new human cancer susceptibility gene for sporadic squamous cell carcinoma of the head and neck (HNSCC).
|
24315737 |
2014 |
|
FANCONI ANEMIA, COMPLEMENTATION GROUP O
|
|
0.700 |
CausalMutation
|
CLINVAR |
RAD51C--a new human cancer susceptibility gene for sporadic squamous cell carcinoma of the head and neck (HNSCC).
|
24315737 |
2014 |
|
FANCONI ANEMIA, COMPLEMENTATION GROUP O
|
|
0.700 |
CausalMutation
|
CLINVAR |
Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes.
|
24549055 |
2014 |
|
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3
|
|
0.700 |
CausalMutation
|
CLINVAR |
Germline mutation in the RAD51B gene confers predisposition to breast cancer.
|
24139550 |
2013 |
|
Neoplastic Syndromes, Hereditary
|
|
0.700 |
CausalMutation
|
CLINVAR |
Germline mutation in the RAD51B gene confers predisposition to breast cancer.
|
24139550 |
2013 |
|
FANCONI ANEMIA, COMPLEMENTATION GROUP O
|
|
0.700 |
CausalMutation
|
CLINVAR |
Germline mutation in the RAD51B gene confers predisposition to breast cancer.
|
24139550 |
2013 |
|
FANCONI ANEMIA, COMPLEMENTATION GROUP O
|
|
0.700 |
CausalMutation
|
CLINVAR |
Germline RAD51C mutations confer susceptibility to ovarian cancer.
|
22538716 |
2012 |
|
Neoplastic Syndromes, Hereditary
|
|
0.700 |
CausalMutation
|
CLINVAR |
Germline RAD51C mutations confer susceptibility to ovarian cancer.
|
22538716 |
2012 |
|
FANCONI ANEMIA, COMPLEMENTATION GROUP O
|
|
0.700 |
CausalMutation
|
CLINVAR |
Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients.
|
21990120 |
2012 |
|
Neoplastic Syndromes, Hereditary
|
|
0.700 |
CausalMutation
|
CLINVAR |
Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.
|
22006311 |
2011 |
|
FANCONI ANEMIA, COMPLEMENTATION GROUP O
|
|
0.700 |
CausalMutation
|
CLINVAR |
Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.
|
22006311 |
2011 |
|
FANCONI ANEMIA, COMPLEMENTATION GROUP O
|
|
0.700 |
CausalMutation
|
CLINVAR |
Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene.
|
20400964 |
2010 |
|
ovarian neoplasm
|
|
0.700 |
GeneticVariation
|
CLINVAR |
|
|
|
|
Neoplastic Syndromes, Hereditary
|
|
0.700 |
GeneticVariation
|
CLINVAR |
|
|
|